SS
TRAW icon

SBI Securities’s Traws Pharma TRAW Stock Holding History

SBI Securities’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45K Buy
1,721
+1,593
+1,245% +$2.19K ﹤0.01% 2671
2026
Q1 		$234 Sell
128
-34
-21% -$64 ﹤0.01% 3164
2025
Q4 		$183 Hold
162
– – ﹤0.01% 3238
2025
Q3 		$300 Hold
162
– – ﹤0.01% 3188
2025
Q2 		$240 Sell
162
-345
-68% -$550 ﹤0.01% 3254
2025
Q1 		$1.17K Buy
507
+352
+227% +$1.83K ﹤0.01% 2511
2024
Q4 		$1.38K Buy
+155
New +$863 ﹤0.01% 2463

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

SBI Securities's TRAW Position: Q2 2026 in Review

SBI Securities increased its Traws Pharma (TRAW) stake by 1,245% in Q2 2026, buying an estimated $2.19K and bringing the position to 1,721 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2671.

SBI Securities first reported a position in TRAW in Q4 2024 and has held it in 7 quarters since. 21 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • SBI Securities held 1,721 shares of Traws Pharma worth $1.45K as of Q2 2026.
  • SBI Securities bought 1,593 Traws Pharma shares in Q2 2026, an estimated $2.19K.
  • Traws Pharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2671 holding.
  • SBI Securities first reported a position in Traws Pharma in Q4 2024 and has held it in 7 quarters since.
  • 21 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.